Enliven Therapeutics CMO Helen Louise Collins disposes of USD 250,000 in common shares - ELVN News | RalliesEnliven Therapeutics CMO Helen Louise Collins disposes of USD 250,000 in common shares
E
ELVN• CMO exercises options and sells shares
- Enliven Therapeutics Chief Medical Officer Helen Louise Collins exercised stock options for 5,000 shares at $2.48 on Sept. 17, 2026.
- Collins sold 5,000 shares the same day at weighted average prices of $50.03, $50.71, and $51.48.
- Beneficial ownership in common stock ended at 25,000 shares following the transactions.
- Derivative holdings show 106,268 stock options remaining after the exercise.
•
